Cox regression analysis of CD33 expression (Q1-3 vs Q4) and other prognostic factors
| . | Multivariate . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OS from study entry . | OS from CR . | DFS from CR . | |||||||||
| n . | HR . | 95% CI . | P . | n . | HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
| CD33 expression | |||||||||||
| Q1-3 | 174 | 1 | 138 | ||||||||
| Q4 | 47 | 1.38 | 0.84-2.28 | .209 | 37 | 2.18 | 1.19-3.99 | .011 | 1.73 | 1.03-2.89 | .038 |
| Risk group (cyto/mutation) | |||||||||||
| Standard | 116 | 1 | 87 | 1 | 1 | ||||||
| Low | 79 | 0.39 | 0.22-0.72 | .002 | 69 | 0.53 | 0.26-1.08 | .082 | 0.72 | 0.43-1.23 | .228 |
| High | 26 | 1.65 | 0.92-2.96 | .091 | 19 | 1.93 | 0.94-3.99 | .074 | 1.48 | 0.76-2.89 | .25 |
| . | Multivariate . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OS from study entry . | OS from CR . | DFS from CR . | |||||||||
| n . | HR . | 95% CI . | P . | n . | HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
| CD33 expression | |||||||||||
| Q1-3 | 174 | 1 | 138 | ||||||||
| Q4 | 47 | 1.38 | 0.84-2.28 | .209 | 37 | 2.18 | 1.19-3.99 | .011 | 1.73 | 1.03-2.89 | .038 |
| Risk group (cyto/mutation) | |||||||||||
| Standard | 116 | 1 | 87 | 1 | 1 | ||||||
| Low | 79 | 0.39 | 0.22-0.72 | .002 | 69 | 0.53 | 0.26-1.08 | .082 | 0.72 | 0.43-1.23 | .228 |
| High | 26 | 1.65 | 0.92-2.96 | .091 | 19 | 1.93 | 0.94-3.99 | .074 | 1.48 | 0.76-2.89 | .25 |